Anti-phospholipid antibody syndrome with skin as a primary involved organ: an interesting case report

Authors

  • Aum N. Soni Department of Dermatology, Shree Pukhraj Raichand General Hospital, Ahmedabad, Gujarat, India
  • Harshad V. Parmar Department of Histopathology, Sterling Accuris Laboratories Limited, Ahmedabad, Gujarat, India
  • Hinal J. Prajapati Department of Dermatology, General Hospital, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20240686

Keywords:

APLA syndrome, Anti-phospholipid antibody, Severe cutaneous necrosis

Abstract

Anti-phospholipid antibody (APLA) syndrome is a multisystem vascular thrombopathy characterized by presence of antibodies against phospholipid antigens. Resulting thrombosis due to these antibodies leads to hallmark obstetric complications, cutaneous and cerebral vascular involvement, pulmonary embolism and thrombosis which can occur in vasculature of any organ system of body. Though APLA syndrome is characterized by pregnancy loss and foetal morbidity, isolated cutaneous or other system presentation has been reported especially in male patients. Here we present an interesting case report of an old aged male patient presenting with cutaneous ulcers and skin involvement as presenting feature.

References

Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013;368:1033-44.

Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, et al. Antiphospholipid syndrome. Nat Rev Dis Primers. 2018;4:17103.

de Jesus GR, Agmon-Levin N, Andrade CA, Andreoli L, Chighizola CB, Porter TF, et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev. 2014;13:795-813.

Lee CW, Park MH. Flank ulcer in a patient with primary antiphospholipid syndrome. J Korean Med Sci. 1999;14:110-2.

Francès C, Niang S, Laffitte E, Pelletier Fl, Costedoat N, Piette JC. Dermatologic manifestations of the antiphospholipid syndrome: Two hundred consecutive cases. Arthritis Rheum. 2005;52:1785-93.

D'souza D, Dandakeri S, Bhat MR, Srinath MK. An atypical presentation of antiphospholipid antibody syndrome. Indian Dermatol Online J. 2015;6(4):263-5.

Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHW, Machin SJ, Barquinero J, et al. The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore). 1989;68:366-74.

Siniscalchi C, Basaglia M, Riva M, Meschi M, Meschi T, Castaldo G, Di Micco P. Catastrophic Antiphospholipid Syndrome: A Review. Immuno. 2024;4(1):1-13.

Chaturvedi S, McCrae KR. Diagnosis and management of the antiphospholipid syndrome. Blood Rev. 2017;31(6):406-17.

Erkan D. Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome. Arthritis Rheumatol. 2021;73:1780-90.

Creamer D, Hunt BJ, Black MM. Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: A report of two cases. Br J Dermatol. 2000;142:1199-203.

Downloads

Published

2024-03-16

Issue

Section

Case Reports